Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / O••••• T••••••••• I•••

O••••• T••••••••• I•••

Stage unknownDallas, TXPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Oct 17, 2025
    Form D equity offering · $15.6M (form d sold) · 10 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “O••••• T••••••••• I••• filed Form D: $15,602,151 sold of $26,702,156, Pharmaceuticals”
  2. May 22, 2024
    Form D equity offering · $50.0M (form d sold) · 16 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “O••••• T••••••••• I••• filed Form D: $49,999,926 sold of $49,999,999, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
People
2 officers, 9 directors
Timeline
2
  1. Nov 5, 2025
    O••••• T••••••••• I••• filed Form D: $15,602,151 sold of $26,702,156, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jun 6, 2024
    O••••• T••••••••• I••• filed Form D: $49,999,926 sold of $49,999,999, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company